Tat peptide-mediated cellular delivery: Back to basics

Advanced Drug Delivery Reviews

Volumn 57, Issue 4 SPEC.ISS., 2005, Pages 559-577

  Brooks, Hilary ^a   Lebleu, Bernard ^a   Vivès, Eric ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Cell delivery; CPP; TAT; Uptake

Indexed keywords

AMINO ACIDS; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; NUCLEIC ACIDS; POLYPEPTIDES; VIRUSES;

CELL NUCLEUS; DRUG DELIVERY TOOLS; HUMAN IMMUNODEFICIENCY VIRUS (HIV); PLASMA MEMBRANES;

PROTEINS;

ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; CARRIER PROTEIN; CRE RECOMBINASE; DOXORUBICIN; LIPOSOME; OLIGOMER; OLIGONUCLEOTIDE; PEROXIDASE; POLYETHYLENEIMINE; POLYMER; RIBONUCLEASE; TRANSACTIVATOR PROTEIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CAVEOLA; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CHEMICAL BOND; CYTOTOXICITY; DNA BINDING MOTIF; DRUG BINDING; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHILICITY; HYDROPHOBICITY; LIPID COMPOSITION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PHYSICAL CHEMISTRY; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

EID: 13844256698     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.12.001     Document Type: Review

References (104)

1. S. Ruben, A. Perkins, R. Purcell, K. Joung, R. Sia, R. Burghoff, W.A. Haseltine, and C.A. Rosen Structural and functional characterization of human immunodeficiency virus tat protein J. Virol. 63 1989 1 8
2. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 664 668
3. E. Vives, P. Brodin, and B. Lebleu A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 1997 16010 16017
4. S. Futaki, T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 2001 5836 5840
5. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2003 585 590
6. M.A. Lindsay Peptide-mediated cell delivery: application in protein target validation Curr. Opin. Pharmacol. 2 2002 587 594
7. M.J. Gait Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues Cell. Mol. Life Sci. 60 2003 844 853
8. M. Zhao, and R. Weissleder Intracellular cargo delivery using tat peptide and derivatives Med. Res. Rev. 24 2004 1 12
9. A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions Pharm. Res. 19 2002 744 754
10. C. Bonny, A. Oberson, S. Negri, C. Sauser, and D.F. Schorderet Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death Diabetes 50 2001 77 82
11. J.S. Wadia, R.V. Stan, and S.F. Dowdy Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10 2004 310 315
12. S. Futaki, I. Nakase, T. Suzuki, Z. Youjun, and Y. Sugiura Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides Biochemistry 41 2002 7925 7930
13. E.P. Loret, E. Vives, P.S. Ho, H. Rochat, J. Van Rietschoten, and W.C. Johnson Jr. Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization Biochemistry 30 1991 6013 6023
14. D. Derossi, A.H. Joliot, G. Chassaing, and A. Prochiantz The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 1994 10444 10450
15. S.D. Kramer, and H. Wunderli-Allenspach No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides Biochim. Biophys. Acta 1609 2003 161 169
16. J.M. Sabatier, E. Vives, K. Mabrouk, A. Benjouad, H. Rochat, A. Duval, B. Hue, and E. Bahraoui Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 J. Virol. 65 1991 961 967
17. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing, and A. Prochiantz Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent J. Biol. Chem. 271 1996 18188 18193
18. P.E. Thoren, D. Persson, P. Isakson, M. Goksor, A. Onfelt, and B. Norden Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells Biochem. Biophys. Res. Commun. 307 2003 100 107
19. J.P. Gratton, J. Yu, J.W. Griffith, R.W. Babbitt, R.S. Scotland, R. Hickey, F.J. Giordano, and W.C. Sessa Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo Nat. Med. 9 2003 357 363
20. T. Suzuki, S. Futaki, M. Niwa, S. Tanaka, K. Ueda, and Y. Sugiura Possible existence of common internalization mechanisms among arginine-rich peptides J. Biol. Chem. 277 2002 2437 2443
21. A. Eguchi, T. Akuta, H. Okuyama, T. Senda, H. Yokoi, H. Inokuchi, S. Fujita, T. Hayakawa, K. Takeda, M. Hasegawa, and M. Nakanishi Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 276 2001 26204 26210
22. Y.L. Tseng, J.J. Liu, and R.L. Hong Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study Mol. Pharmacol. 62 2002 864 872
23. U. Koppelhus, S.K. Awasthi, V. Zachar, H.U. Holst, P. Ebbesen, and P.E. Nielsen Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates Antisense Nucleic Acid Drug Dev. 12 2002 51 63
24. A. Ferrari, V. Pellegrini, C. Arcangeli, A. Fittipaldi, M. Giacca, and F. Beltram Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time Molec. Ther. 8 2003 284 294
25. C. Rudolph, C. Plank, J. Lausier, U. Schillinger, R.H. Muller, and J. Rosenecker Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells J. Biol. Chem. 8 2003 8
26. J.C. Mai, H. Shen, S.C. Watkins, T. Cheng, and P.D. Robbins Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate J. Biol. Chem. 277 2002 30208 30218
27. P.O. Falnes, J. Wesche, and S. Olsnes Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment Biochemistry 40 2001 4349 4358
28. A. Nori, K.D. Jensen, M. Tijerina, P. Kopeckova, and J. Kopecek Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells Bioconjug. Chem. 14 2003 44 50
29. S. Sandgren, F. Cheng, and M. Belting Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans J. Biol. Chem. 277 2002 38877 38883
30. R. Bhorade, R. Weissleder, T. Nakakoshi, A. Moore, and C.H. Tung Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide Bioconjug. Chem. 11 2000 301 305
31. S. Console, C. Marty, C. Garcia-Echeverria, R. Schwendener, and K. Ballmer-Hofer Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans J. Biol. Chem. 278 2003 35109 35114
32. E.L. Snyder, B.R. Meade, and S.F. Dowdy Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function J. Control. Release 91 2003 45 51
33. V.P. Torchilin, and T.S. Levchenko TAT-Liposomes: a novel intracellular drug carrier Curr. Protein Pept. Sci. 4 2003 133 140
34. I.A. Ignatovich, E.B. Dizhe, A.V. Pavlotskaya, B.N. Akifiev, S.V. Burov, S.V. Orlov, and A.P. Perevozchikov Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways J. Biol. Chem. 278 2003 42625 42636
35. S. Violini, V. Sharma, J.L. Prior, M. Dyszlewski, and D. Piwnica-Worms Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate Biochemistry 41 2002 12652 12661
36. V.P. Torchilin, T.S. Levchenko, R. Rammohan, N. Volodina, B. Papahadjopoulos-Sternberg, and G.G. D'Souza Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes Proc. Natl. Acad. Sci. U. S. A. 100 2003 1972 1977
37. V.P. Torchilin, R. Rammohan, V. Weissig, and T.S. Levchenko TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. U. S. A. 98 2001 8786 8791
38. P.E. Thoren, D. Persson, M. Karlsson, and B. Norden The antennapedia peptide penetratin translocates across lipid bilayers-the first direct observation FEBS Lett. 482 2000 265 268
39. E. Vives, C. Granier, P. Prevot, and B. Lebleu Structure activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein Lett. Pept. Sci. 4 1997 429 436
40. P.A. Wender, D.J. Mitchell, K. Pattabiraman, E.T. Pelkey, L. Steinman, and J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U. S. A. 97 2000 13003 13008
41. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, and J.B. Rothbard Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res. 56 2000 318 325
42. L.R. Wright, J.B. Rothbard, and P.A. Wender Guanidinium rich peptide transporters and drug delivery Curr. Protein Pept. Sci. 4 2003 105 124
43. O. Zelphati, and F.J. Szoka Mechanism of oligonucleotide release from cationic liposomes Proc. Natl. Acad. Sci. U. S. A. 93 1996 11493 11498
44. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
45. S.R. Schwarze, and S.F. Dowdy In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA Trends Pharmacol. Sci. 21 2000 45 48
46. J.S. Wadia, and S.F. Dowdy Protein transduction technology Curr. Opin. Biotechnol. 13 2002 52 56
47. R. Montesano, J. Roth, A. Robert, and L. Orci Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins Nature 296 1982 651 653
48. L. Pelkmans, J. Kartenbeck, and A. Helenius Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER Nat. Cell Biol. 3 2001 473 483
49. J. Alblas, L. Ulfman, P. Hordijk, and L. Koenderman Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes Mol. Biol. Cell 12 2001 2137 2145
50. H.M. Moulton, M.H. Nelson, S.A. Hatlevig, M.T. Reddy, and P.L. Iversen Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides Bioconjug. Chem. 15 2004 290 299
51. L.L. Chen, A.D. Frankel, J.L. Harder, S. Fawell, J. Barsoum, and B. Pepinsky Increased cellular uptake of the human immunodeficiency virus-1 Tat protein after modification with biotin Anal. Biochem. 227 1995 168 175
52. S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, and Y. Sugiura Stearylated arginine-rich peptides: a new class of transfection systems Bioconjug. Chem. 12 2001 1005 1011
53. P. Sazani, S.H. Kang, M.A. Maier, C. Wei, J. Dillman, J. Summerton, M. Manoharan, and R. Kole Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs Nucleic Acids Res. 29 2001 3965 3974
54. S. Futaki Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms Int. J. Pharm. 245 2002 1 7
55. J. Kyte, and R.F. Doolittle A simple method for displaying the hydropathic character of a protein J. Mol. Biol. 157 1982 105 132
56. M. Hallbrink, A. Floren, A. Elmquist, M. Pooga, T. Bartfai, and U. Langel Cargo delivery kinetics of cell-penetrating peptides Biochim. Biophys. Acta 1515 2001 101 109
57. F. Albericio, D. Andreu, E. Giralt, C. Navalpotro, E. Pedroso, B. Ponsati, and M. Ruiz-Gayo Use of the Npys thiol protection in solid phase peptide synthesis. Application to direct peptide-protein conjugation through cysteine residues Int. J. Pept. Protein Res. 34 1989 124 128
58. M.S. Bernatowicz, R. Matsueda, and G.R. Matsueda Preparation of Boc-[S-(3-nitro-2-pyridinesulfenyl)]-cysteine and its use for unsymmetrical disulfide bond formation Int. J. Pept. Protein Res. 28 1986 107 112
59. E. Vives, and B. Lebleu Selective coupling of a highly basic peptide to an oligonucleotide Tetrahedron Lett. 38 1997 1183 1186
60. B. Lebleu, I. Robbins, L. Bastide, E. Vives, and J.E. Gee Pharmacokinetics of oligonucleotides in cell culture Ciba Found. Symp. 209 1997 47 54 discussion 54-49
61. T. Zhu, Z. Wei, C.H. Tung, W.A. Dickerhof, K.J. Breslauer, D.E. Georgopoulos, M.J. Leibowitz, and S. Stein Oligonucleotide-poly-l-ornithine conjugates: binding to complementary DNA and RNA Antisense Res. Dev. 3 1993 265 275
62. Z. Wei, C.H. Tung, T. Zhu, W.A. Dickerhof, K.J. Breslauer, D.E. Georgopoulos, M.J. Leibowitz, and S. Stein Hybridization properties of oligodeoxynucleotide pairs bridged by polyarginine peptides Nucleic Acids Res. 24 1996 655 661
63. E.P. Feener, W.C. Shen, and H.J. Ryser Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes J. Biol. Chem. 265 1990 18780 18785
64. H.M. Moulton, and J.D. Moulton Peptide-assisted delivery of steric-blocking antisense oligomers Curr. Opin. Mol. Ther. 5 2003 123 132
65. C. Tung, S. Mueller, and R. Weissleder Novel branching membrane translocational peptide as gene delivery vector Bioorg. Med. Chem. 10 2002 3609
66. M. Lewin, N. Carlesso, C.H. Tung, X.W. Tang, D. Cory, D.T. Scadden, and R. Weissleder Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat. Biotechnol. 18 2000 410 414
67. M. Lundberg, and M. Johansson Positively charged DNA-binding proteins cause apparent cell membrane translocation Biochem. Biophys. Res. Commun. 291 2002 367 371
68. M. Lundberg, S. Wikstrom, and M. Johansson Cell surface adherence and endocytosis of protein transduction domains Molec. Ther. 8 2003 143 150
69. D.C. Anderson, E. Nichols, R. Manger, D. Woodle, M. Barry, and A.R. Fritzberg Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide Biochem. Biophys. Res. Commun. 194 1993 876 884
70. A. Astriab-Fisher, D.S. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates Biochem. Pharmacol. 60 2000 83 90
71. A. Fittipaldi, A. Ferrari, M. Zoppe, C. Arcangeli, V. Pellegrini, F. Beltram, and M. Giacca Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 tat fusion proteins J. Biol. Chem. 278 2003 34141 34149
72. M. Rusnati, C. Urbinati, A. Caputo, L. Possati, H. Lortat-Jacob, M. Giacca, D. Ribatti, and M. Presta Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat J. Biol. Chem. 276 2001 22420 22425
73. M. Rusnati, G. Taraboletti, C. Urbinati, G. Tulipano, R. Giuliani, M.P. Molinari-Tosatti, B. Sennino, M. Giacca, M. Tyagi, A. Albini, D. Noonan, R. Giavazzi, and M. Presta Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat FASEB J. 14 2000 1917 1930
74. M. Rusnati, G. Tulipano, C. Urbinati, E. Tanghetti, R. Giuliani, M. Giacca, M. Ciomei, A. Corallini, and M. Presta The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists J. Biol. Chem. 273 1998 16027 16037
75. D.A. Mann, and A.D. Frankel Endocytosis and targeting of exogenous HIV-1 Tat protein EMBO J. 10 1991 1733 1739
76. M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans J. Biol. Chem. 276 2001 3254 3261
77. M. Rusnati, D. Coltrini, P. Oreste, G. Zoppetti, A. Albini, D. Noonan, F. d'Adda di Fagagna, M. Giacca, and M. Presta Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size J. Biol. Chem. 272 1997 11313 11320
78. H.C. Chang, F. Samaniego, B.C. Nair, L. Buonaguro, and B. Ensoli HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region Aids 11 1997 1421 1431
79. M. Salmivirta, K. Lidholt, and U. Lindahl Heparan sulfate: a piece of information FASEB J. 10 1996 1270 1279
80. T. Jackson, F.M. Ellard, R.A. Ghazaleh, S.M. Brookes, W.E. Blakemore, A.H. Corteyn, D.I. Stuart, J.W. Newman, and A.M. King Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate J. Virol. 70 1996 5282 5287
81. E.E. Fry, S.M. Lea, T. Jackson, J.W. Newman, F.M. Ellard, W.E. Blakemore, R. Abu-Ghazaleh, A. Samuel, A.M. King, and D.I. Stuart The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex EMBO J. 18 1999 543 554
82. A. Yayon, M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64 1991 841 848
83. T. Arai, W. Busby Jr., and D.R. Clemmons Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix Endocrinology 137 1996 4571 4575
84. D. Mohanraj, T. Olson, and S. Ramakrishnan A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast Biochem. Biophys. Res. Commun. 215 1995 750 756
85. A. Albini, R. Benelli, M. Presta, M. Rusnati, M. Ziche, A. Rubartelli, G. Paglialunga, F. Bussolino, and D. Noonan HIV-tat protein is a heparin-binding angiogenic growth factor Oncogene 12 1996 289 297
86. Y.G. Brickman, M.D. Ford, D.H. Small, P.F. Bartlett, and V. Nurcombe Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells J. Biol. Chem. 270 1995 24941 24948
87. J.S. Bartlett, R. Wilcher, and R.J. Samulski Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors J. Virol. 74 2000 2777 2785
88. I.I. Fuki, R.V. Iozzo, and K.J. Williams Perlecan heparan sulfate proteoglycan. A novel receptor that mediates a distinct pathway for ligand catabolism J. Biol. Chem. 275 2000 31554
89. K.J. Williams, and I.V. Fuki Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism Curr. Opin. Lipidol. 8 1997 253 262
90. K.S. Rost, and J.D. Esko Microbial adherence to and invasion through proteoglycans Infect. Immun. 65 1997 1 8
91. K. Lidholt, J.L. Weinke, C.S. Kiser, F.N. Lugemwa, K.J. Bame, S. Cheifetz, J. Massague, U. Lindahl, and J.D. Esko A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis Proc. Natl. Acad. Sci. U. S. A. 89 1992 2267 2271
92. M. Silhol, M. Tyagi, M. Giacca, B. Lebleu, and E. Vives Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat Eur. J. Biochem. 269 2002 494 501
93. Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath, and J.J. He Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands Nat. Med. 6 2000 1380 1387
94. M. Feligioni, L. Raiteri, R. Pattarini, M. Grilli, S. Bruzzone, P. Cavazzani, M. Raiteri, and A. Pittaluga The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms J. Neurosci. 23 2003 6810 6818
95. B.E. Vogel, S.J. Lee, A. Hildebrand, W. Craig, M.D. Pierschbacher, F. Wong-Staal, and E. Ruoslahti A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin J. Cell Biol. 121 1993 461 468
96. B.S. Weeks, K. Desai, P.M. Loewenstein, M.E. Klotman, P.E. Klotman, M. Green, and H.K. Kleinman Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein J. Biol. Chem. 268 1993 5279 5284
97. R. Katoh-Semba, A. Oohira, and S. Kashiwamata Nerve growth factor-induced changes in the structure of sulfated proteoglycans in PC12 pheochromocytoma cells J. Neurochem. 59 1992 282 289
98. M. Rusnati, G. Tulipano, D. Spillmann, E. Tanghetti, P. Oreste, G. Zoppetti, M. Giacca, and M. Presta Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides J. Biol. Chem. 274 1999 28198 28205
99. T.B. Potocky, A.K. Menon, and S.H. Gellman Cytoplasmic and nuclear delivery of a TAT-derived peptide and a {beta}-peptide after endocytic uptake into HeLa cells J. Biol. Chem. 278 2003 50188 50194
100. R. Fischer, K. Kohler, M. Fotin-Mleczek, and R. Brock A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides J. Biol. Chem. 279 2004 12625 12635
101. T. Fujimoto, H. Kogo, K. Ishiguro, K. Tauchi, and R. Nomura Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell J. Cell Biol. 152 2001 1079 1085
102. A.D. Frankel, and C.O. Pabo Cellular uptake of the tat protein from human immunodeficiency virus Cell 55 1988 1189 1193
103. G. Kilic, R.B. Doctor, and J.G. Fitz Insulin stimulates membrane conductance in a liver cell line: evidence for insertion of ion channels through a phosphoinositide 3-kinase-dependent mechanism J. Biol. Chem. 276 2001 26762 26768
104. E.M. Neuhaus, and T. Soldati A myosin I is involved in membrane recycling from early endosomes J. Cell Biol. 150 2000 1013 1026